Re: The rats are jumping off the sunk ship while Erck The Criminal continues to dilute shareholders in to oblivion
Novavax has experienced significant attrition as the result of the ResVax trial and the Catalent merger. The evidence is in the latest 10-K. NOvanax was close to 400 employees earlier this year. They lost about 100 as a result of the Catalent deal, and are down to under 200 employees. That leaves about 100 unaccounted for, which means they were lost through attrition. Novavax only has about half the employees it had a year ago.